[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Yang et al., 2020 - Google Patents

COVID-19 in elderly adults: clinical features, molecular mechanisms, and proposed strategies

Yang et al., 2020

View HTML
Document ID
13271194889790295500
Author
Yang Y
Zhao Y
Zhang F
Zhang L
Li L
Publication year
Publication venue
Aging and disease

External Links

Snippet

Abstract Coronavirus disease 2019 (COVID-19) is causing problems worldwide. Most people are susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but elderly populations are more susceptible. Elevated susceptibility and death rates in …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

Similar Documents

Publication Publication Date Title
Muralidar et al. The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
Soumya et al. Impact of COVID-19 on the cardiovascular system: a review of available reports
Shu et al. Coronavirus disease‑2019
Davoudi-Monfared et al. A randomized clinical trial of the efficacy and safety of interferon β-1a in treatment of severe COVID-19
Hosoki et al. Molecular mechanisms and epidemiology of COVID-19 from an allergist’s perspective
Yang et al. COVID-19 in elderly adults: clinical features, molecular mechanisms, and proposed strategies
Khan et al. Coronaviruses disease 2019 (COVID-19): causative agent, mental health concerns, and potential management options
Davoudi-Monfared et al. Efficacy and safety of interferon β-1a in treatment of severe COVID-19: A randomized clinical trial
Bhagat et al. Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease
Pedreañez et al. SARS-CoV-2 infection represents a high risk for the elderly: analysis of pathogenesis
Jia et al. Role of tumor necrosis factor-α in the mortality of hospitalized patients with severe and critical COVID-19 pneumonia
Scarpa et al. May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)?
Monticelli et al. Why does SARS-CoV-2 hit in different ways? Host genetic factors can influence the acquisition or the course of COVID-19
Bouazza et al. Are patients with asthma and chronic obstructive pulmonary disease preferred targets of COVID-19?
Dezfuli et al. Update on immunology of COVID-19 disease and potential strategy for controlling
Chen et al. The immune mechanism of the nasal epithelium in COVID-19–related olfactory dysfunction
Zhao et al. From COVID-19 to sarcoidosis: how similar are these two diseases?
Kashani et al. Molecular and clinical investigation of covid-19: from pathogenesis and immune responses to novel diagnosis and treatment
Jami et al. Characterization of the angiotensin-converting enzyme 2 (ACE2), the main receptor for the SARS-CoV-2 virus
Cheng et al. Ablation of microglia following infection of the central nervous system with a neurotropic murine coronavirus infection leads to increased demyelination and impaired remyelination
Younger Coronavirus 2019: clinical and neuropathological aspects
Mascolo et al. SARS‐CoV‐2 and inflammatory responses: From mechanisms to the potential therapeutic use of intravenous immunoglobulin
Rufaida et al. A dossier on COVID-19 chronicle
Darbeheshti et al. Coronavirus: pure infectious disease or genetic predisposition
Feng et al. Kidney involvement in coronavirus‑associated diseases